![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright © 2006, The Rockefeller University Press Article NF-κB translocation prevents host cell death after low-dose challenge by Legionella pneumophila 1Howard Hughes Medical Institute and 2Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111 CORRESPONDENCE Ralph R. Isberg: Ralph.Isberg/at/tufts.edu Received April 7, 2006; Accepted August 2, 2006. This article has been cited by other articles in PMC.Abstract Legionella pneumophila, the causative agent of Legionnaires' disease, grows within macrophages and manipulates target cell signaling. Formation of a Legionella-containing replication vacuole requires the function of the bacterial type IV secretion system (Dot/Icm), which transfers protein substrates into the host cell cytoplasm. A global microarray analysis was used to examine the response of human macrophage-like U937 cells to low-dose infections with L. pneumophila. The most striking change in expression was the Dot/Icm-dependent up-regulation of antiapoptotic genes positively controlled by the transcriptional regulator nuclear factor κB (NF-κB). Consistent with this finding, L. pneumophila triggered nuclear localization of NF-κB in human and mouse macrophages in a Dot/Icm-dependent manner. The mechanism of activation at low-dose infections involved a signaling pathway that occurred independently of the Toll-like receptor adaptor MyD88 and the cytoplasmic sensor Nod1. In contrast, high multiplicity of infection conditions caused a host cell response that masked the unique Dot/Icm-dependent activation of NF-κB. Inhibition of NF-κB translocation into the nucleus resulted in premature host cell death and termination of bacterial replication. In the absence of one antiapoptotic protein, plasminogen activator inhibitor–2, host cell death increased in response to L. pneumophila infection, indicating that induction of antiapoptotic genes is critical for host cell survival. Legionella pneumophila is the causative agent of Legionnaires's disease (1). The microorganism is a Gram-negative facultative intracellular bacterial pathogen that can grow in culture, as well as replicate within fresh water amoeba and mammalian cells (2). On internalization by macrophages or amoeba, L. pneumophila avoids fusion with the endocytic pathway and establishes a replication vacuole, which develops into a rough ER-like compartment (3–5). Legionella replicates within this compartment for up to 24 h, at which time the vacuole fills the host cell cytoplasm before lysis and liberation of intracellular bacteria. Biogenesis of the L. pneumophila replication vacuole requires a functional Dot/Icm apparatus, which is similar to other type IV secretion systems that promote conjugative DNA transfer and translocation of proteins into target host cells (6). In the absence of Dot/Icm, the bacteria target into an endocytic compartment and fail to replicate (7, 8). Genetic and bioinformatics strategies have identified a large cadre of protein substrates that are translocated by this apparatus, and there appears to be considerable functional redundancy among these translocated proteins in regards to supporting L. pneumophila intracellular growth (9–14). Although there has been extensive work on the L. pneumophila–encoded proteins required for growth within macrophages, it is still unclear what host cell factors regulate L. pneumophila growth. Several studies have identified common and specific host cell responses after contact with other bacterial pathogens, usually after challenging cells with bacteria at high multiplicities, to ensure the entire population of host cells contacts the pathogen (15–18). In the case of L. pneumophila, such a global analysis of gene expression patterns in the amoeba Dictyostelium discoideum has been performed (19). Most of the transcriptional changes occurred at 24 h after infection (hai), when L. pneumophila initiated replication in this study. Some of the major transcriptional changes reported include induction of heat shock proteins, tRNA synthetase genes, and repression of calcium-binding proteins involved in signal transduction (19). More directed analyses of cytokines and transporters produced by target host cells in response to L. pneumophila have been performed, and there is selective induction of TNF-α and IL-1α, IL-1β, and IL-6 in peritoneal A/J mouse macrophages (20). The transcriptional expression of another cytokine, IL-12, is variable and is probably dependent on specific experimental conditions (21, 22). In addition, one study identified an amino acid transporter, slc1a5, whose expression is required for L. pneumophila growth within human monocytes (23). To understand the macrophage signaling pathways important for L. pneumophila growth, we investigated the global transcriptional response of host cells harboring a single bacterium. This highly sensitive approach allowed for maximum bacterial replication and minimized host cell cytotoxicity. We found that among the genes induced under these conditions were ones that encode antiapoptotic proteins. The antiapoptotic response appeared tightly linked to NF-κB activation, supporting a role for this regulator in L. pneumophila intracellular growth that involves the maintenance of host cell survival after challenge with low doses of bacteria. RESULTS Low-dose challenge with L. pneumophila and enrichment of infected macrophages To identify host cell genes that may modulate intracellular growth of L. pneumophila, we compared the transcriptional profile of U937 cells incubated with either WT L. pneumophila (Dot+) or a dotA− mutant lacking a functional Dot/Icm translocator (24, 25). The isolation of a homogenously infected cell population was a prerequisite for this study. Unlike other pathogens, L. pneumophila causes rapid Dot/Icm-dependent cytotoxicity at the high multiplicities of infection (MOIs) (26) that are required to infect the majority of cells in the monolayer. To bypass cytotoxicity, all incubations were performed at MOI = 1 (one bacterium per macrophage), which results in a minority of the cultured cells having associated bacteria. To specifically analyze this population, U937 cells having associated bacteria were then sorted away from the vast excess of uninfected cells using the GFP marker (Fig. 1 A
Samples were collected 1 or 8 hai and sorted for the cell population harboring GFP bacteria, and total RNA was isolated from these sorted populations. These two time points were chosen because the Dot+ strain initiates biogenesis of the replication vacuole at 1 hai, with clear recruitment of ER-derived vesicles at this time point (5), and has completed one round of division by 8 hai (Fig. 1 B To confirm that any changes in expression patterns were a result of a response to functions performed by the type IV translocation system, the mutant strain dimB− was included in this study. The dimB− mutant has an intact Dot/Icm translocator and shows proper formation of a replication vacuole but is defective for intracellular growth and stalls after one intracellular doubling (unpublished data). The peak fluorescence intensity of U937 cells infected with dimB−-GFP was identical to that observed for Dot+-GFP at 1 and 8 hai, as expected for a mutant that stalls after this time point (unpublished data). Low-dose infection caused substantial changes in macrophage gene transcription Total RNA from the enriched population of U937 cells harboring L. pneumophila was analyzed by probing oligonucleotide microarrays representing 21,173 human genes (see Materials and methods). Differentially expressed genes were identified and subjected to hierarchical clustering to reveal gene expression trends (see Materials and methods; Fig. 2
Association of host cells with the Dot+ strain induces major changes in genes regulating immune response, heat shock, and vesicle trafficking By 8 hai, Dot+-GFP induced transcription of a subset of the proinflammatory cytokines tnfα, il1α, and il1β, as well as the chemokine il8. Expression of il8 was verified by qPCR, and relative induction levels were similar to those found on the arrays (Fig. 3
We also observed induction of several heat shock genes (hsp40, hsdj2, hsph1, hsp72, and hsp90) in response to Dot+-GFP, but not dotA−-GFP (Table I). Two were DnaJ chaperone family members (hsp40 and hsdj2). In addition to their roles in protein folding, Hsp72, Hsp90, Hsp40, and Hdj2 have roles in interfering with apoptosis (27), which plays a critical role in supporting L. pneumophila replication, as will be shown below. Multiple genes encoding proteins involved in membrane vesicle interactions were induced in response to the strain with an intact Dot/Icm translocator (Table I). Induction of expression of the snap23, rab8b, and rab9 genes was verified by qPCR to be dependent on an intact Dot/Icm translocator (Fig. 3 Activation of NF-κB pathway and manipulation of host cell survival The most striking result from the analysis of low MOI challenge was that genes regulated by the mitogen-activated protein (MAP) kinase and NF-κB signaling pathways showed intense levels of response to Dot+-GFP but not dotA−-GFP infection (Table II). Although induction of the MAP kinase and NF-κB signaling pathways has been observed to be a general response to bacterial components at high MOI (17), in this case the response is specific to strains having an intact Dot/Icm translocator.
Dual specificity phosphatases 1, 2, and 6 (dusp1, 2, and 6), which down-modulate MAP kinase pathways, were among the most highly induced genes on arrays, and qPCR analysis showed even higher levels of up-regulation with 100-fold induction of dusp1 (Fig. 3 The NF-κB family includes five transcription factors: p65 (RelA), p50, p52, Relb, and c-Rel. The subunits form homo- and heterodimers, and the canonical form is p50-p65. Translocation of these NF-κB dimers from the cytoplasm to the nucleus is necessary for activation of this signaling pathway. Because p65 is known to regulate antiapoptotic gene expression (32, 34), we tested whether nuclear translocation of NF-κB p65 occurs in response to L. pneumophila. U937 cells were infected at MOI = 1 with Dot+ or dotA− strains lacking the GFP plasmid, and the cells harboring bacteria were analyzed by immunofluorescence microscopy for localization of p65. The NF-κB subunit p65 was detected in the nucleus at 6 hai in individual cells associated with Dot+, whereas there was no substantial nuclear p65 staining in cells harboring dotA− at MOI = 1 (Fig. 4 A
To further analyze the response of NF-κB to L. pneumophila in primary macrophages, p65 translocation was evaluated in BM macrophages from A/J mice (see Materials and methods). In general, the response of these mouse macrophages was more rapid than that observed in U937 cells, with 50% and 80% of the cells harboring Dot+ showing NF-κB nuclear staining by 1 and 14 hai, respectively (Fig. 4, A and C As is true of mutations in most dot/icm genes, lesions in dotA prevent function of the type IV complex. The absence of the IcmS chaperone, however, allows Dot/Icm function but causes defective translocation of a subset of substrates (13, 37). To determine if these substrates were required for NF-κB translocation, p65 nuclear localization was analyzed during an icmS− infection. Nuclear localization of p65 was partly dependent on icmS in U937 cells at early time points (Fig. 4 D NF-κB translocation is necessary to promote host cell survival after L. pneumophila infection NF-κB nuclear translocation may be required for host cell survival during L. pneumophila infection to maintain a niche for L. pneumophila replication. To address this possibility, the overexpression of the dominant-negative form of IκB, IκBDN, was used to inhibit NF-κB translocation (38). Specifically, BM macrophages from A/J mice were transduced with a retrovirus expressing either GFP alone or IκBDN-IRES-GFP followed by infection with Dot+ or dotA− at MOI = 1. At 2 hai, nuclear localization of NF-κB p65 was detected in ~70% of the GFP-producing cells harboring Dot+ bacteria, whereas NF-κB translocation was almost completely inhibited in infected macrophages expressing IκBDN (Figs. 5, A and B
To investigate whether lack of NF-κB translocation inhibits intracellular growth of L. pneumophila, cultures were treated with caffeic acid phenethyl ester (CAPE), which is known to block translocation of NF-κB (39). This assay is not only an independent measure of the consequences of NF-κB inhibition, but it also allowed us to evaluate a larger number of infected cells in the monolayer than we could with IκBDN transduction assay. A/J BM macrophages were pretreated with CAPE at 10 μg/ml for 2 h and incubated with Dot+ or dotA− as described above, and NF-κB translocation, cell death, and bacterial replication were determined. Translocation of p65 was efficiently inhibited by CAPE in Dot+-infected macrophages at both 1 and 6 hai (Fig. 6, A and B
Many of the NF-κB–regulated antiapoptotic proteins identified in the arrays could contribute to protecting from host cell death after L. pneumophila infection (Table II). To address whether a single antiapoptotic protein among this group contributed to host cell survival, we used BM macrophages derived from a plasminogen activator inhibitor–2 (PAI-2)–deficient C57BL/6 mouse, which has been shown to be more susceptible to LPS-stimulated cell death (33). To determine if this protein contributes to host cell survival in response to L. pneumophila, macrophages were isolated from the C57BL/6 pai-2−/− mouse strain and challenged with L. pneumophila flaA−, which has been shown to grow in the normally restrictive C57BL/6 background (40, 41). By 6 hai, we observed a 2.5-fold increase in cell death in PAI-2–deficient macrophages compared with the C57BL/6 control (P < 0.0005, determined by the Student's t test; Fig. 7 A
Dot+ NF-κB activation is independent of MyD88 and Nod1 Toll-like receptors (TLRs) have been shown to activate NF-κB transcription factors in response to bacterial macromolecules. In several experiments, engagement of a variety of TLRs results in signaling that is mediated at least in part by the adaptor molecule MyD88 (42). To determine whether the observed NF-κB activation is dependent on MyD88 signaling, BM macrophages from MyD88-deficient and C57BL/6 control mice were used for L. pneumophila infections. Consistent with previous experiments, NF-κB translocation was readily observed in macrophages infected by dotA− at MOI = 5 but only marginally at MOI = 1 in the control C57BL/6 BM macrophages (Fig. 7 B A pathway exists for NF-κB activation via the cytosolic sensor Nod, which recognizes intracellularly localized peptidoglycan products (43). There is evidence that peptidoglycan products are delivered across the plasma membrane by the Helicobacter pylori type IV secretion system, promoting Nod1-dependent NF-κB activation, so it is possible that Dot/Icm uses a similar strategy to promote translocation of p65 (44). To determine if activation of NF-κB by the Dot/Icm system is dependent on Nod1, we compared Nod1-deficient C57BL/6 BM macrophages with a heterozygous littermate control. L. pneumophila incubation with macrophages derived from the two mouse strains showed no considerable difference in p65 translocation (Fig. 7 C DISCUSSION In this paper we analyzed the gene expression patterns of host cells harboring a single bacterium after incubation with different L. pneumophila strains. This strategy allowed us to identify >200 genes that were differentially expressed in response to events promoted by the L. pneumophila Dot/Icm secretion system. Most striking among the panel of differentially expressed genes was the induction of antiapoptotic genes, many of which are positively regulated by transcription factor NF-κB p65 (32, 34). It has been reported that L. pneumophila strain AA100 can induce apoptosis in U937 cells at high doses of bacteria (45). We found that the L. pneumophila Philadelphia 1 strain only causes small increases in cell death at low MOIs and instead stimulates an antiapoptotic response (46). Inducing apoptosis with staurosporine or TNF-α has been shown to be restrictive for L. pneumophila replication (46). Thus, interference with cell death is critical for optimal growth of the L. pneumophila and, based on our experiments, is dependent on NF-κB p65 translocation, at least in mouse BM macrophages. The importance of this response was emphasized by the fact that blocking NF-κB translocation by CAPE or expression of dominant-negative IκB resulted in premature cell death in BM macrophages incubated with the Dot+ strain. Both the activation of the NF-κB cell survival pathway and stimulation of cell death in the absence of NF-κB translocation were dependent on a functional type IV secretion system, as the dotA− strain did not induce cell death under any condition used in this study. Several intracellular pathogens have been shown to activate the NF-κB–antiapoptotic pathway. For instance, host cell survival after infection with parasites such as Toxoplasma gondii (47) or bacteria such as Rickettsia ricketsii (48) is associated with NF-κB translocation. NF-κB can be activated by engagement of TLRs at the host cell surface in response to microbial molecules that are present on both pathogens and nonpathogens (43, 49). TLR2 and TLR5, in fact, are engaged by surface-exposed L. pneumophila LPS and flagellum, respectively (50, 51), but at low bacterial doses it seems unlikely that these common TLR ligands activate NF-κB translocation. Under conditions in which translocation of NF-κB was dependent on the Dot/Icm system, we observed nuclear localization of this protein in both the absence of MyD88 and with strains lacking the flagellin protein, arguing against activation occurring via TLR2 or TLR5. The dependence on the type IV system for nuclear localization of NF-κB, however, could be bypassed by challenging macrophages with the dotA− strain at high MOIs. Under this condition, elevated MOIs allowed signaling through the adaptor MyD88 to promote nuclear localization of NF-κB. One route for bypass of the MyD88 adaptor occurs via the intracellular signaling molecules Nod1 and Nod2, which are involved in recognition of bacterial peptidoglycan (43). It has been suggested that the extracellular pathogen H. pylori activates NF-κB via Nod1 by translocating peptidoglycan into the host cell through its type IV secretion system (44). In contrast, we observed that NF-κB translocation after L. pneumophila challenge occurred independently of Nod1, which is consistent with a model in which protein substrates of the Dot/Icm system stimulate this event and promote host cell survival. In the absence of Nod1, however, Nod2 may still sense peptidoglycan released through L. pneumophila's type IV secretion system, so this experiment does not totally eliminate the possibility that a substrate other than protein is the inducer of NF-κB translocation. If a protein is an inducer, then it must be transferred in a process that is largely independent of the L. pneumophila IcmS/IcmW chaperone, which is involved in the egress of a subset of the type IV secretion substrates (13). Alternatively, the observed nuclear localization of p65 could be a direct result of contact of the Dot/Icm apparatus with the host cell. In addition to activating antiapoptotic pathways, the NF-κB family of transcription factors is known to control many proinflammatory processes. We observed selective strong induction of proinflammatory cytokines TNF-α, IL-1α, and IL-1β, which is consistent with previous observations (20), as well as the induction of the chemokine IL-8. These inflammatory genes all are activated in part by NF-κB (52). In general, however, there was a lack of response of type I IFN–regulated genes. It has been recently reported that IL-6 and IFN-β are highly induced by opsonized L. pneumophila in restrictive C57BL/6 MyD88/Trif double knockout macrophages (53). The discrepancy in these results may be caused by the fact that our analysis used conditions that favored intracellular growth rather than restriction. Furthermore, the host and bacterial strains that were analyzed in our experiments were different from those used in this previous study (53). When we directly assayed for secretion of IL-6 using BM macrophages from A/J mice and the Dot+ bacterial strain used in our experiments, IL-6 production was not apparent until 13 hai, a time at which the intracellular replication cycle is close to being completed and bacteria liberated from host cells begin to appear in the culture (unpublished data). Heat shock genes were induced in host cells at 8 hai in response to a strain encoding an intact Dot/Icm translocator. Heat shock genes were also shown to be induced in Dictyostelium discoideum in response to L. pneumophila infection (19) and may be playing similar roles in both host cell types. L. pneumophila effector proteins are deposited across the translocation channel, presumably in either an unfolded or partially folded form, which may induce the heat shock response and potentially facilitate the folding of translocated effectors. In addition, Hsps are known to play a role in preventing apoptosis (27), and their induction may support L. pneumophila replication in a manner similar to that proposed for NF-κB. The L. pneumophila replication vacuole intercepts vesicles derived from the ER and destined for the cis-Golgi, yet the Golgi remains intact throughout the intracellular replication cycle (54). To compensate for perturbation caused by the formation of the replication vacuole, it might have been predicted that the cell would up-regulate components involved in ER to Golgi traffic, but we found no evidence for this occurring at the transcriptional level. Instead, there was induction of a distinct subset of genes encoding proteins that appeared to participate in traffic between the trans-Golgi network and either the plasma membrane or various endocytic compartments (Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20060766/DC1). These may be involved in maintaining Golgi integrity via a retrograde pathway. Alternatively, these proteins may facilitate cytokine secretion, as the soluble NSF attachment protein syntaxin 6 (stx6) is involved in the secretion of TNF-α (55), and both stx6 and tnfα were found to be induced after L. pneumophila infection (Table I). In conclusion, we have performed a global screen for host cell genes differentially expressed during L. pneumophila infection at a low infectious dose, with unexpected findings. We have shown that NF-κB translocation is stimulated by the L. pneumophila virulence system and is required to support bacterial intracellular growth within mouse macrophages. Therefore, the NF-κB signaling pathway is likely to be a major target for manipulation by the L. pneumophila type IV secretion system. Continued research on this signaling will help to uncover the mechanism used by L. pneumophila to regulate this pathway and control intracellular growth. MATERIALS AND METHODS Bacterial strains and media. L. pneumophila philadelphia 1 strains Lp02 (thyA, referred to as Dot+) and Lp03 (dotA−, referred to as dotA−) are derivatives of Lp01 (hsdR rpsL) (56). The dimB− mutant (Lp02 dimB) has the kanamycin resistance transposon miniTn10(kan) in the open reading frame Lpg2815. The icmS mutant was generated as previously described (37), and the icmS complementing plasmid pMMB207icmS+ (pCR43) was provided by Craig Roy (Yale University School of Medicine, New Haven, CT) (37). Lp02-flaA− (referred to as Dot+-flaA−) was provided by Tao Ren and William Dietrich (Harvard Medical School, Boston, MA). L. pneumophila strains carrying GFP on an isopropyl-β-D-thiogalactopyranoside (IPTG)–inducible plasmid have been described previously (57). L. pneumophila strains were maintained on buffered charcoal yeast extract solid medium and ACES-buffered yeast extract broth culture media (58–60). GFP strains were maintained on medium containing 100 μg thymidine/ml and 5 μg chloramphenicol/ml and grown in liquid culture containing 100 μg/ml thymidine and 1 mM IPTG. Cell culture. U937 cells (American Type Culture Collection) were grown in RPMI 1640 (Irvine) supplemented with 10% heat-inactivated fetal bovine serum (Hyclone) and 1 mM glutamine (Invitrogen). 5 × 107 U937 cells were differentiated using 10 ng/ml 12-tetradecanoyl phorbol 13-acetate (TPA) for 48 h in a T175 tissue culture flask, after which cells were washed, replated with fresh media in the absence of TPA, and used for incubations with L. pneumophila ~16 h later. A/J and C57BL/6 BM-derived macrophages were isolated from the femurs of 6–8-wk-old female mice and prepared by standard procedures (58). C57BL/6 myd88−/− femurs were provided by Sarah Stanley in the laboratory of Jeffrey Cox (University of California, San Francisco, San Francisco, CA), and permission to use these mice in our study was granted by Shizuo Akira (Osaka University, Osaka, Japan). Femurs from C57BL/6 pai2−/− mice were provided by Randal Westrick in the laboratory of David Ginsburg (University of Michigan Medical School, Ann Arbor, MI). Femurs from nod1+/− and nod1−/− littermates were provided by Mary O'Riordan (University of Michigan Medical School, Ann Arbor, MI). Macrophages were isolated from femurs and differentiated for 7 d, collected, and frozen for use in multiple experiments in media containing 20% serum, 10% DMSO. Macrophages were replated in RPMI medium supplemented with 10% heat-inactivated fetal bovine serum and 1 mM glutamine for use. Flow cytometry sorting. 5 × 107 TPA-differentiated U937 cells were replated in 10 cm tissue culture dishes in RPMI medium containing 10% FBS, 200 μg/ml thymidine, and 1 mM IPTG. After ~16 h of incubation at 37°C, the U937 cells were infected with L. pneumophila grown in AYE broth medium to a post-exponential phase (A600, OD 3.5–4), as judged by the presence of motility in at least 50% of the bacteria observed in 40× fields (61). Individual plates were infected with Dot+-GFP (Lp02), dimB−-GFP, or dotA−-GFP adjusted to MOI = 1 bacterium/macrophage, assuming that 109 bacteria is equivalent to A600 = 1. Bacteria were then pelleted onto the monolayers by a 5-min centrifugation at 1,000 rpm in a tabletop centrifuge fitted with tissue culture plate carriers to synchronize infections, incubated at 37°C, 5% C02 for 1 h, and then washed three times before adding fresh medium. 1 or 8 h after centrifugation, uninfected (mock) or L. pneumophila-infected U937 cells were lifted by washing the monolayer once with PBS + 0.1 mM EDTA and then treating with 0.05% Trypsin-EDTA solution (Invitrogen) for 1 min. Complete RPMI/10% FBS medium was added back immediately, and cells were collected by centrifugation at 1,000 RPM. U937 cells were then resuspended in <1 ml of media to concentrate the suspension. Cells were sorted at Tufts Laser Cytometry facility (http://www.tufts.edu/med/research/TLC.html) using a FACS (MoFlo; DakoCytomation), and appropriate gates were collected for further analysis. For each sample, 1–2 × 106 GFP-positive cells and mock uninfected cells were sorted. Microarray analysis. QIAGEN oligonucleotide microarrays (Human v2.1.2) were printed by and purchased from Tufts University Expression Analysis Core facility (TEAC; http://www.tufts.edu/med/teac/index.html). According to TEAC-provided protocols, 10–20 μg of total RNA was isolated from U937 cells using an RNAeasy kit (QIAGEN) according to the manufacturer's instructions. Total RNA was reverse transcribed with superscript II RT (Invitrogen) to incorporate the modified nucleotide 5-(3-aminoallyl)-dUTP (Ambion) into cDNA. The resulting reactions were purified on GFX columns (Cyscribe; GE Healthcare) and coupled with either Cy3 or Cy5 normal human serum ester dye (GE Healthcare) in 50 mM NaHC03 (pH 9). As a reference, cDNA isolated from uninfected, unsorted U937 cells were always labeled with Cy3, and the sorted sample or high MOI sample was always labeled with Cy5. CyDye-labeled cDNA was purified on the Cyscribe GFX column, and incorporation of CyDye was quantitated spectrophotometrically to normalize each sample set. Reference Cy3- and Cy5-labeled cDNAs were hybridized in 1× GE Healthcare hybridization buffer and 10% formamide in a Corning hybridization chamber for 48 h at 42°C. Glass slides were washed with increasing stringency in 1 × SSC, 0.2% SDS, followed by 0.1 × SSC, 0.2% SDS, and 0.1 × SSC buffers. The glass microarrays were spun dry and scanned immediately (ScanArray 4000; Packard Instrument Co.). Microarray accession data are provided in Tables I and II and Table S1. Microarray data analysis. Hybridization levels were measured using analysis software (Imagene; Biodiscovery). Exported raw gene expression data was imported into a microarray program (Genespring; Agilent Technologies) for further analysis. The mean of expression levels for individual genes from three independent microarrays performed on cells isolated from three independent infections were used to identify differentially expressed genes. Genes were considered to be induced or repressed when the ratio of sorted sample/reference (unsorted and uninfected) was >2 or <0.5 on a log scale of normalized intensities (lowest intensity dependent on normalization) and generated a p-value < 0.05 by the Student's t test. The one-way analysis of variance test was used to select differentially expressed genes comparing U937 cells incubated with Dot+-GFP, dimB−-GFP, dotA−-GFP (all at MOI = 1), dotA−-GFP (at MOI = 10), or mock infections. Hierarchical clustering to identify gene expression trends was performed using Pearson correlation. qPCR. 1 μg of total RNA from sorted cell samples and references was first reverse transcribed using superscript II RT (Invitrogen) in a total reaction volume of 60 μl containing DNase/Rnase-free water and a buffer suggested by the manufacturer. 1 μl of the resulting cDNA reaction mix was then used for qPCR analysis. qPCR was then performed using the GenAmp5700 system with the SYBR green PCR reagent (Applied Biosystems). Primer sequences are available on request. For each quantification, three reactions were performed in parallel, results were normalized based on a β-actin mRNA control, and mean values were calculated. Real-time PCR reactions were performed in duplicate, and all results were found to be highly reproducible. Retroviral transduction. pCLXSN-IκBDN-IRES-GFP and pCLXSN-GFP vectors were provided by James B. Bliska (State University of New York at Stony Brook, Stony Brook, NY). Retroviral transductions were performed as previously described (38, 62), with the following modifications. A/J BM macrophages grown for 7–8 d were used for transductions. Macrophages were cultured on glass coverslips in fresh retroviral 293T supernatant for 48 h using 24-well plates. The transduced macrophages were than washed with fresh media containing 200 μg/ml thymidine and incubated with bacteria 30 min later. NF-κB translocation assay. For immunofluorescence analyses, mammalian cells (either U937 cells or BM macrophages) were plated at a density of 2–3 × 105 cells per well with 200 μg/ ml thymidine on coverslips placed in 24-well dishes. For incubations with host cells, Dot+, dotA−, or Dot+-flaA were grown to the post-exponential phase, and cell monolayers were infected as previously described (10). Cells were allowed to continue to incubate in fresh RPMI/FBS medium for the times noted in the figures and were then fixed with 3.7% paraformaldehyde in PBS for 20 min at room temperature. Fixed cells were permeabilized with 0.1% Triton X-100 in PBS for 10–20 min at room temperature, blocked in PBS containing 4% goat serum (Invitrogen) for 30 min, stained with primary rat anti–L. pneumophila serum (1:10,000) and rabbit anti-p65 (1:1,000; Santa Cruz Biotechnology, Inc.) in PBS containing 4% goat serum overnight at 4°C. Appropriate secondary antibodies were used, either goat anti–rat IgG conjugated to Texas red (Invitrogen), donkey anti–rabbit IgG conjugated to FITC (Jackson ImmunoResearch Laboratories), and/or goat anti–rabbit IgG conjugated to AlexaFluor 594 (Invitrogen). Nuclei were stained using Hoechst DNA dye (1:10,000; Invitrogen). Microscope images were taken using a 100× 1.4 NA lens on a microscope (IM200; Carl Zeiss MicroImaging, Inc.). Contrast and brightness of individual channels were adjusted linearly in Photoshop (Adobe). Online supplemental material. Table S1 contains the complete list of differentially expressed genes from the hierarchical cluster shown in Fig. 2 [Supplemental Material Index]
Acknowledgments We would like to thank Molly Bergman, Marion Dorer, Matthias Machner, Vicki Stone, and Joyce Yang for reviews of this manuscript. We thank Shizuo Akira, Tao Ren, Craig Roy, James Bliska, and Sarah Stanley for gifts of mouse and bacterial strains. We also thank Randal Westrick for providing BM from pai2−/− mice and Mary O'Riordan for bone marrow from nod1−/− mice. Ralph R. Isberg is an investigator of the Howard Hughes Medical Institute (HHMI), and this work was supported by HHMI and Training Grant T32AI1007422. The authors have no conflicting financial interest. Notes Abbreviations used: CAPE, caffeic acid phenethyl ester; Dot+, WT Legionella pneumophila; hai, h after infection; MAP, mitogen-activated protein; MOI, multiplicity of infection; PAI-2, plasminogen activator inhibitor–2; qPCR, quantitative real-time PCR; TLR, Toll-like receptor. References 1. Fraser, D.W., T.R. Tsai, W. Orenstein, W.E. Parkin, H.J. Beecham, R.G. Sharrar, J. Harris, G.F. Mallison, S.M. Martin, J.E. McDade, et al. 1977. Legionnaires' disease: description of an epidemic of pneumonia. N. Engl. J. Med. 297:1189–1197. [PubMed] 2. Fields, B.S. 1996. The molecular ecology of Legionellae. Trends Microbiol. 4:286–290. [PubMed] 3. Horwitz, M.A. 1983. Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes. J. Exp. Med. 158:1319–1331. [PubMed] 4. Horwitz, M.A. 1983. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J. Exp. Med. 158:2108–2126. [PubMed] 5. Tilney, L.G., O.S. Harb, P.S. Connelly, C.G. Robinson, and C.R. Roy. 2001. How the parasitic bacterium Legionella pneumophila modifies its phagosome and transforms it into rough ER: implications for conversion of plasma membrane to the ER membrane. J. Cell Sci. 114:4637–4650. [PubMed] 6. Christie, P.J. 2001. Type IV secretion: intercellular transfer of macromolecules by systems ancestrally related to conjugation machines. Mol. Microbiol. 40:294–305. [PubMed] 7. Segal, G., M. Purcell, and H.A. Shuman. 1998. Host cell killing and bacterial conjugation require overlapping sets of genes within a 22-kb region of the Legionella pneumophila genome. Proc. Natl. Acad. Sci. USA. 95:1669–1674. [PubMed] 8. Vogel, J.P., H.L. Andrews, S.K. Wong, and R.R. Isberg. 1998. Conjugative transfer by the virulence system of Legionella pneumophila. Science. 279:873–876. [PubMed] 9. Campodonico, E.M., L. Chesnel, and C.R. Roy. 2005. A yeast genetic system for the identification and characterization of substrate proteins transferred into host cells by the Legionella pneumophila Dot/Icm system. Mol. Microbiol. 56:918–933. [PubMed] 10. Conover, G.M., I. Derre, J.P. Vogel, and R.R. Isberg. 2003. The Legionella pneumophila LidA protein: a translocated substrate of the Dot/Icm system associated with maintenance of bacterial integrity. Mol. Microbiol. 48:305–321. [PubMed] 11. Luo, Z.Q., and R.R. Isberg. 2004. Multiple substrates of the Legionella pneumophila Dot/Icm system identified by interbacterial protein transfer. Proc. Natl. Acad. Sci. USA. 101:841–846. [PubMed] 12. Nagai, H., J.C. Kagan, X. Zhu, R.A. Kahn, and C.R. Roy. 2002. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science. 295:679–682. [PubMed] 13. Ninio, S., D.M. Zuckman-Cholon, E.D. Cambronne, and C.R. Roy. 2005. The Legionella IcmS-IcmW protein complex is important for Dot/Icm-mediated protein translocation. Mol. Microbiol. 55:912–926. [PubMed] 14. Shohdy, N., J.A. Efe, S.D. Emr, and H.A. Shuman. 2005. Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking. Proc. Natl. Acad. Sci. USA. 102:4866–4871. [PubMed] 15. Rosenberger, C.M., M.G. Scott, M.R. Gold, R.E. Hancock, and B.B. Finlay. 2000. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J. Immunol. 164:5894–5904. [PubMed] 16. McCaffrey, R.L., P. Fawcett, M. O'Riordan, K.D. Lee, E.A. Havell, P.O. Brown, and D.A. Portnoy. 2004. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc. Natl. Acad. Sci. USA. 101:11386–11391. [PubMed] 17. Jenner, R.G., and R.A. Young. 2005. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3:281–294. [PubMed] 18. Guillemin, K., N.R. Salama, L.S. Tompkins, and S. Falkow. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA. 99:15136–15141. [PubMed] 19. Farbrother, P., C. Wagner, J. Na, B. Tunggai, T. Morio, H. Urushihara, Y. Tanaka, M. Schleicher, M. Steinert, and L. Eichinger. 2005. Dictyostelium transcriptional host cell response upon infection with Legionella. Cell. Microbiol. 8:438–456. 20. McHugh, S.L., Y. Yamamoto, T.W. Klein, and H. Friedman. 2000. Murine macrophages differentially produce proinflammatory cytokines after infection with virulent vs. avirulent Legionella pneumophila. J. Leukoc. Biol. 67:863–868. [PubMed] 21. Matsunaga, K., T.W. Klein, C. Newton, H. Friedman, and Y. Yamamoto. 2001. Legionella pneumophila suppresses interleukin-12 production by macrophages. Infect. Immun. 69:1929–1933. [PubMed] 22. Neild, A.L., and C.R. Roy. 2003. Legionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation. Immunity. 18:813–823. [PubMed] 23. Wieland, H., S. Ullrich, F. Lang, and B. Neumeister. 2005. Intracellular multiplication of Legionella pneumophila depends on host cell amino acid transporter SLC1A5. Mol. Microbiol. 55:1528–1537. [PubMed] 24. Roy, C.R., K.H. Berger, and R.R. Isberg. 1998. Legionella pneumophila DotA protein is required for early phagosome trafficking decisions that occur within minutes of bacterial uptake. Mol. Microbiol. 28:663–674. [PubMed] 25. Roy, C.R., and R.R. Isberg. 1997. Topology of Legionella pneumophila DotA: an inner membrane protein required for replication in macrophages. Infect. Immun. 65:571–578. [PubMed] 26. Kirby, J.E., J.P. Vogel, H.L. Andrews, and R.R. Isberg. 1998. Evidence for pore-forming ability by Legionella pneumophila. Mol. Microbiol. 27:323–336. [PubMed] 27. Beere, H.M. 2004. “The stress of dying”: the role of heat shock proteins in the regulation of apoptosis. J. Cell Sci. 117:2641–2651. [PubMed] 28. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 120:649–661. [PubMed] 29. Matsuda, A., Y. Suzuki, G. Honda, S. Muramatsu, O. Matsuzaki, Y. Nagano, T. Doi, K. Shimotohno, T. Harada, E. Nishida, et al. 2003. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways. Oncogene. 22:3307–3318. [PubMed] 30. Muzio, M., J. Ni, P. Feng, and V.M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1612–1615. [PubMed] 31. Heyninck, K., and R. Beyaert. 2005. A20 inhibits NF-κB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30:1–4. [PubMed] 32. Wang, C.Y., M.W. Mayo, R.G. Korneluk, D.V. Goeddel, and A.S. Baldwin Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1680–1683. [PubMed] 33. Park, J.M., F.R. Greten, A. Wong, R.J. Westrick, J.S. Arthur, K. Otsu, A. Hoffmann, M. Montminy, and M. Karin. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-κB as key regulators. Immunity. 23:319–329. [PubMed] 34. Zong, W.X., L.C. Edelstein, C. Chen, J. Bash, and C. Gelinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13:382–387. [PubMed] 35. Deveraux, Q.L., and J.C. Reed. 1999. IAP family proteins–suppressors of apoptosis. Genes Dev. 13:239–252. [PubMed] 36. Werner, A.B., E. de Vries, S.W. Tait, I. Bontjer, and J. Borst. 2002. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 277:22781–22788. [PubMed] 37. Coers, J., J.C. Kagan, M. Matthews, H. Nagai, D.M. Zuckman, and C.R. Roy. 2000. Identification of Icm protein complexes that play distinct roles in the biogenesis of an organelle permissive for Legionella pneumophila intracellular growth. Mol. Microbiol. 38:719–736. [PubMed] 38. Zhang, Y., A.T. Ting, K.B. Marcu, and J.B. Bliska. 2005. Inhibition of MAPK and NF-κB pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J. Immunol. 174:7939–7949. [PubMed] 39. Natarajan, K., S. Singh, T.R. Burke Jr., D. Grunberger, and B.B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. USA. 93:9090–9095. [PubMed] 40. Molofsky, A.B., B.G. Byrne, N.N. Whitfield, C.A. Madigan, E.T. Fuse, K. Tateda, and M.S. Swanson. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203:1093–1104. [PubMed] 41. Ren, T., D.S. Zamboni, C.R. Roy, W.F. Dietrich, and R.E. Vance. 2006. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog. 2:e18. [PubMed] 42. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13:816–825. [PubMed] 43. Philpott, D.J., and S.E. Girardin. 2004. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41:1099–1108. [PubMed] 44. Viala, J., C. Chaput, I.G. Boneca, A. Cardona, S.E. Girardin, A.P. Moran, R. Athman, S. Memet, M.R. Huerre, A.J. Coyle, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166–1174. [PubMed] 45. Gao, L.Y., and Y. Abu Kwaik. 1999. Apoptosis in macrophages and alveolar epithelial cells during early stages of infection by Legionella pneumophila and its role in cytopathogenicity. Infect. Immun. 67:862–870. [PubMed] 46. Abu-Zant, A., M. Santic, M. Molmeret, S. Jones, J. Helbig, and Y. Abu Kwaik. 2005. Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila. Infect. Immun. 73:5339–5349. [PubMed] 47. Molestina, R.E., T.M. Payne, I. Coppens, and A.P. Sinai. 2003. Activation of NF-κB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IκB to the parasitophorous vacuole membrane. J. Cell Sci. 116:4359–4371. [PubMed] 48. Clifton, D.R., R.A. Goss, S.K. Sahni, D. van Antwerp, R.B. Baggs, V.J. Marder, D.J. Silverman, and L.A. Sporn. 1998. NF-κB-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection. Proc. Natl. Acad. Sci. USA. 95:4646–4651. [PubMed] 49. Naumann, M. 2000. NF-κB activation and innate immune response in microbial pathogen infection. Biochem. Pharmacol. 60:1109–1114. [PubMed] 50. Girard, R., T. Pedron, S. Uematsu, V. Balloy, M. Chignard, S. Akira, and R. Chaby. 2003. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci. 116:293–302. [PubMed] 51. Hawn, T.R., A. Verbon, K.D. Lettinga, L.P. Zhao, S.S. Li, R.J. Laws, S.J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, et al. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J. Exp. Med. 198:1563–1572. [PubMed] 52. Blackwell, T.S., and J.W. Christman. 1997. The role of NF-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:3–9. [PubMed] 53. Stetson, D.B., and R. Medzhitov. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 24:93–103. [PubMed] 54. Derre, I., and R.R. Isberg. 2005. LidA, a translocated substrate of the Legionella pneumophila type IV secretion system, interferes with the early secretory pathway. Infect. Immun. 73:4370–4380. [PubMed] 55. Murray, R.Z., F.G. Wylie, T. Khromykh, D.A. Hume, and J.L. Stow. 2005. Syntaxin 6 and Vti1b form a novel SNARE complex, which is up-regulated in activated macrophages to facilitate exocytosis of tumor necrosis factor-alpha. J. Biol. Chem. 280:10478–10483. [PubMed] 56. Berger, K.H., and R.R. Isberg. 1993. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol. Microbiol. 7:7–19. [PubMed] 57. Solomon, J.M., A. Rupper, J.A. Cardelli, and R.R. Isberg. 2000. Intracellular growth of Legionella pneumophila in Dictyostelium discoideum, a system for genetic analysis of host-pathogen interactions. Infect. Immun. 68:2939–2947. [PubMed] 58. Swanson, M.S., and R.R. Isberg. 1995. Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect. Immun. 63:3609–3620. [PubMed] 59. Gabay, J.E., M. Blake, W.D. Niles, and M.A. Horwitz. 1985. Purification of Legionella pneumophila major outer membrane protein and demonstration that it is a porin. J. Bacteriol. 162:85–91. [PubMed] 60. Feeley, J.C., R.J. Gibson, G.W. Gorman, N.C. Langford, J.K. Rasheed, D.C. Mackel, and W.B. Baine. 1979. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J. Clin. Microbiol. 10:437–441. [PubMed] 61. Byrne, B., and M.S. Swanson. 1998. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect. Immun. 66:3029–3034. [PubMed] 62. Zhang, Y., and J.B. Bliska. 2003. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect. Immun. 71:1513–1519. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
N Engl J Med. 1977 Dec 1; 297(22):1189-97.
[N Engl J Med. 1977]Trends Microbiol. 1996 Jul; 4(7):286-90.
[Trends Microbiol. 1996]J Exp Med. 1983 Oct 1; 158(4):1319-31.
[J Exp Med. 1983]J Cell Sci. 2001 Dec; 114(Pt 24):4637-50.
[J Cell Sci. 2001]Mol Microbiol. 2001 Apr; 40(2):294-305.
[Mol Microbiol. 2001]Proc Natl Acad Sci U S A. 1998 Feb 17; 95(4):1669-74.
[Proc Natl Acad Sci U S A. 1998]Science. 1998 Feb 6; 279(5352):873-6.
[Science. 1998]Mol Microbiol. 2005 May; 56(4):918-33.
[Mol Microbiol. 2005]Proc Natl Acad Sci U S A. 2005 Mar 29; 102(13):4866-71.
[Proc Natl Acad Sci U S A. 2005]J Immunol. 2000 Jun 1; 164(11):5894-904.
[J Immunol. 2000]Proc Natl Acad Sci U S A. 2002 Nov 12; 99(23):15136-41.
[Proc Natl Acad Sci U S A. 2002]J Leukoc Biol. 2000 Jun; 67(6):863-8.
[J Leukoc Biol. 2000]Infect Immun. 2001 Mar; 69(3):1929-33.
[Infect Immun. 2001]Immunity. 2003 Jun; 18(6):813-23.
[Immunity. 2003]Mol Microbiol. 1998 May; 28(3):663-74.
[Mol Microbiol. 1998]Infect Immun. 1997 Feb; 65(2):571-8.
[Infect Immun. 1997]Mol Microbiol. 1998 Jan; 27(2):323-36.
[Mol Microbiol. 1998]J Cell Sci. 2001 Dec; 114(Pt 24):4637-50.
[J Cell Sci. 2001]N Engl J Med. 1977 Dec 1; 297(22):1189-97.
[N Engl J Med. 1977]J Cell Sci. 2004 Jun 1; 117(Pt 13):2641-51.
[J Cell Sci. 2004]Nat Rev Microbiol. 2005 Apr; 3(4):281-94.
[Nat Rev Microbiol. 2005]Cell. 2005 Mar 11; 120(5):649-61.
[Cell. 2005]Oncogene. 2003 May 22; 22(21):3307-18.
[Oncogene. 2003]Science. 1997 Nov 28; 278(5343):1612-5.
[Science. 1997]Trends Biochem Sci. 2005 Jan; 30(1):1-4.
[Trends Biochem Sci. 2005]Science. 1998 Sep 11; 281(5383):1680-3.
[Science. 1998]Science. 1998 Sep 11; 281(5383):1680-3.
[Science. 1998]Genes Dev. 1999 Feb 15; 13(4):382-7.
[Genes Dev. 1999]Mol Microbiol. 2005 Feb; 55(3):912-26.
[Mol Microbiol. 2005]Mol Microbiol. 2000 Nov; 38(4):719-36.
[Mol Microbiol. 2000]J Immunol. 2005 Jun 15; 174(12):7939-49.
[J Immunol. 2005]J Immunol. 2005 Jun 15; 174(12):7939-49.
[J Immunol. 2005]Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):9090-5.
[Proc Natl Acad Sci U S A. 1996]Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):9090-5.
[Proc Natl Acad Sci U S A. 1996]Immunity. 2005 Sep; 23(3):319-29.
[Immunity. 2005]J Exp Med. 2006 Apr 17; 203(4):1093-104.
[J Exp Med. 2006]PLoS Pathog. 2006 Mar; 2(3):e18.
[PLoS Pathog. 2006]Cell Death Differ. 2006 May; 13(5):816-25.
[Cell Death Differ. 2006]Mol Immunol. 2004 Nov; 41(11):1099-108.
[Mol Immunol. 2004]Nat Immunol. 2004 Nov; 5(11):1166-74.
[Nat Immunol. 2004]Science. 1998 Sep 11; 281(5383):1680-3.
[Science. 1998]Genes Dev. 1999 Feb 15; 13(4):382-7.
[Genes Dev. 1999]Infect Immun. 1999 Feb; 67(2):862-70.
[Infect Immun. 1999]Infect Immun. 2005 Sep; 73(9):5339-49.
[Infect Immun. 2005]J Cell Sci. 2003 Nov 1; 116(Pt 21):4359-71.
[J Cell Sci. 2003]Proc Natl Acad Sci U S A. 1998 Apr 14; 95(8):4646-51.
[Proc Natl Acad Sci U S A. 1998]Mol Immunol. 2004 Nov; 41(11):1099-108.
[Mol Immunol. 2004]Biochem Pharmacol. 2000 Oct 15; 60(8):1109-14.
[Biochem Pharmacol. 2000]J Cell Sci. 2003 Jan 15; 116(Pt 2):293-302.
[J Cell Sci. 2003]Mol Immunol. 2004 Nov; 41(11):1099-108.
[Mol Immunol. 2004]Nat Immunol. 2004 Nov; 5(11):1166-74.
[Nat Immunol. 2004]Mol Microbiol. 2005 Feb; 55(3):912-26.
[Mol Microbiol. 2005]J Leukoc Biol. 2000 Jun; 67(6):863-8.
[J Leukoc Biol. 2000]Am J Respir Cell Mol Biol. 1997 Jul; 17(1):3-9.
[Am J Respir Cell Mol Biol. 1997]Immunity. 2006 Jan; 24(1):93-103.
[Immunity. 2006]J Cell Sci. 2004 Jun 1; 117(Pt 13):2641-51.
[J Cell Sci. 2004]Infect Immun. 2005 Jul; 73(7):4370-80.
[Infect Immun. 2005]J Biol Chem. 2005 Mar 18; 280(11):10478-83.
[J Biol Chem. 2005]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 2000 Nov; 38(4):719-36.
[Mol Microbiol. 2000]Infect Immun. 2000 May; 68(5):2939-47.
[Infect Immun. 2000]Infect Immun. 1995 Sep; 63(9):3609-20.
[Infect Immun. 1995]J Clin Microbiol. 1979 Oct; 10(4):437-41.
[J Clin Microbiol. 1979]Infect Immun. 1995 Sep; 63(9):3609-20.
[Infect Immun. 1995]Infect Immun. 1998 Jul; 66(7):3029-34.
[Infect Immun. 1998]J Immunol. 2005 Jun 15; 174(12):7939-49.
[J Immunol. 2005]Infect Immun. 2003 Mar; 71(3):1513-9.
[Infect Immun. 2003]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]